Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Selpercatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8ELI LILLY AND CO

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 40MG

    Approval Date : 2020-05-08

    Application Number : 213246

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 80MG

    Approval Date : 2020-05-08

    Application Number : 213246

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : TABLET;ORAL

    Dosage Strength : 40MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : TABLET;ORAL

    Dosage Strength : 80MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : TABLET;ORAL

    Dosage Strength : 120MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : TABLET;ORAL

    Dosage Strength : 160MG

    Approval Date : 2024-04-10

    Application Number : 218160

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 40MG

    Approval Date :

    Application Number : 218160

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ELI LILLY AND CO

    U.S.A
    CPhI Japan
    Not Confirmed
    arrow

    ELI LILLY AND CO

    U.S.A
    arrow
    CPhI Japan
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    SELPERCATINIB

    Brand Name : RETEVMO

    Dosage Form : CAPSULE;ORAL

    Dosage Strength : 80MG

    Approval Date :

    Application Number : 218160

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.